Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

476.91
-10.8100-2.22%
Post-market: 476.910.00000.00%19:30 EDT
Volume:374.37K
Turnover:178.60M
Market Cap:11.00B
PE:-33.55
High:492.33
Open:486.37
Low:466.06
Close:487.72
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:1.41
T/O Rate:2.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:20.99
PE(LYR):-37.11

Loading ...

Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Biogen (BIIB) and Cadrenal Therapeutics, Inc. (CVKD)

TIPRANKS
·
Jul 14

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Madrigal Pharmaceuticals (MDGL) and Krystal Biotech (KRYS)

TIPRANKS
·
Jul 14

Madrigal Pharmaceuticals' Three New Patents Support Patent Extension Into 2045, Truist Says

MT Newswires Live
·
Jul 14

Madrigal Wins Three New US Patents for MASH Drug Rezdiffra, Boosting IP Protection

Reuters
·
Jul 13

Madrigal Grants New Hires 604 Stock Options, 2,952 Restricted Stock Units Under Inducement Plan

Reuters
·
Jul 07

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 07

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 07

Will Madrigal’s New siRNA MASH Candidate Shift Madrigal Pharmaceuticals' (MDGL) Rezdiffra-Centric Narrative

Simply Wall St.
·
Jul 04

Suzhou Ribo Hits First Milestone in Madrigal Sirna Collaboration for MASH Drug Candidate

Reuters
·
Jul 02

Medicare Coverage Could Put These Obesity Drug Stocks In Focus

Simply Wall St.
·
Jun 30

Madrigal Pharmaceuticals grants 1,397 inducement RSUs to five new employees under 2025 plan

Reuters
·
Jun 23

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 23

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 23

Madrigal Pharmaceuticals adopts nonqualified deferred compensation plan effective Aug. 1

Reuters
·
Jun 18

Madrigal Pharmaceuticals Is Maintained at Neutral by B of A Securities

Dow Jones
·
Jun 11

BofA Securities Adjusts Madrigal Pharmaceuticals Price Target to $542 From $550

MT Newswires Live
·
Jun 11

A Look At Madrigal Pharmaceuticals (MDGL) Valuation After New Rezdiffra Data And Analyst Upgrades

Simply Wall St.
·
Jun 06

Madrigal grants 6,881 inducement RSUs to 20 new employees under 2025 plan

Reuters
·
Jun 05

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 05

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 05